Navigation Links
Alexza Provides Pipeline Update
Date:7/31/2014

MOUNTAIN VIEW, Calif., July 31, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on its pipeline and new product development efforts. In the second half of 2014, Alexza expects to initiate a Phase 2a study of AZ-002 (Staccato® alprazolam), which is being developed for the management of patients with acute repetitive seizures.  Additionally, Alexza has identified two new Staccato-based product candidates for development - AZ-008 and AZ-009 - which will incorporate the active pharmaceutical ingredient ropinirole, a dopamine agonist, into Alexza's proprietary Staccato system.  The Company plans to develop AZ-008 for the acute treatment of restless legs syndrome (RLS) and AZ-009 for hypomobility, or freezing, during "off periods" in Parkinson's disease (PD) patients.

"We have made good progress towards initiating the AZ-002 Phase 2a proof-of-concept study in epilepsy patients and plan to enroll the first patient in the second half of 2014," said James V. Cassella, PhD, Executive Vice President, Research and Development and Chief Scientific Officer of Alexza.  "We have been working with key opinion leaders in this field to finalize the protocol and our overall development strategy, and we look forward to being back in the clinic with AZ-002."

Cassella continued, "On the pipeline side, over the last nine months we have conducted a broad review of medical need in major therapeutic areas.  Through this process, we identified a number of product concepts that aligned with our Staccato technology.  We selected Staccato ropinirole as the basis of the next product candidates planned in our pipeline, based upon our belief of the need for better therapies for patients with RLS or PD.  We feel that AZ-
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
2. Alexza Receives Complete Response Letter for Adasuve™ NDA
3. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexza Pharmaceuticals Inc.
4. Alexza Announces Reverse Stock Split in Order to Maintain NASDAQ Listing
5. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
6. Alexza Announces Management Promotions
7. Alexza Reports 2012 Second Quarter Financial Results and Provides Business Update
8. Alexza Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference
9. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
10. Alexza to Report 2012 Year-End Financial Results on Tuesday, March 26, 2013
11. Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... DUBLIN , May 27, 2015 /PRNewswire/ ... ) has announced the addition of the  ... Testing Market"  report to their offering. ... ,Major issues pertaining to the UK NAT ... regulatory, demographic, social and technological trends with ...
(Date:5/27/2015)... 2015 Research and ... of the  "2015 Strategies in the Global ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... of the orthopedics market, including forecasts for ... categories. , ,In addition, the report presents ...
(Date:5/27/2015)... 27, 2015 Research ... addition of the  "2015 Strategies in the ... to their offering.       (Logo: ... designed to help current suppliers and potential ... emerging in the French coagulation testing market ...
Breaking Medicine Technology:Global Orthopedics Market Strategies 2015 2United States Hemostasis Diagnostic Testing Market Strategies 2015 2
... Abaxis, Inc. (NasdaqGS: ABAX), a medical products company ... has been appointed to the Company,s Board of Directors, ... seven the number of members on the Abaxis board ... Mr. Altman is Senior Advisor of Bain & ...
... May 2, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... subsidiary, Watson Laboratories, Inc., has launched an authorized ... as part of an exclusive agreement with Ortho-McNeil-Janssen ... today.  Concerta is approved for the treatment of ...
Cached Medicine Technology:Abaxis Appoints Vernon Altman to Board of Directors 2Abaxis Appoints Vernon Altman to Board of Directors 3Watson Launches Generic Concerta® 2Watson Launches Generic Concerta® 3
(Date:5/27/2015)... California (PRWEB) May 27, 2015 Western ... marked by a few historic firsts -- and one ... the Pasadena Civic Center marked the first time the ... the first time a Graduate College of Biomedical Sciences ... of the Pacific (COMP). , The university’s fifth and ...
(Date:5/27/2015)... As the U.S. Supreme Court considers the ... the Affordable Care Act (ACA), an investigation by the ... RAND Corporation and Express Scripts provides an unprecedented look ... enrollees. , The analysis is published online as ... also appear in the journal’s June issue. , The ...
(Date:5/27/2015)... 2015 Ticket Down is a reputable source for ... have been super hot during the 2014-15 NBA season and they ... with a final score of 118-88. , For the ... since 2006-2007 when they lost to the San Antonio Spurs. ... of the Cavaliers making it to the NBA finals increased tenfold. ...
(Date:5/27/2015)... Beverly Hills, CA (PRWEB) May 27, 2015 ... state of the art web portal focussed on keratoconus ... disease. This relentless progressive disease has its onset in the ... quieting down. The cornea or the front clear part of ... withstand the pressure in the eye. It results in poor ...
(Date:5/27/2015)... BBB Code of Business Practices represents sound advertising, selling ... confidence in business. The Code is built on the ... elements of creating and maintaining trust in business. This ... Businesses based in the United States and Canada that ... accredited by BBB. , To be accredited by the ...
Breaking Medicine News(10 mins):Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 3Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 4Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 5Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 3Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 4Health News:Cavs NBA Finals Tickets: Ticket Down Slashes Ticket Prices on Cleveland Cavaliers 2015 NBA Finals Tickets at Quicken Loans Arena and Offers Valuable Promo Code 2Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2Health News:Carson Energy Receives A+ Accredited Rating For 19 Consecutive Years 2
... Global climate change will not only impact plants and animals ... that perform a myriad of functions important to life on ... will be, but they could be significant and will probably ... in Boston. , Microbes perform a number of critical functions ...
... National Alliance on,Mental Illness (NAMI) will holds its ... featuring leading experts, policymakers and,individuals and families living ... issues, including the latest scientific and medical advances ... issues., NAMI will honor TV journalist Jane ...
... passage would strip illustrators of essential rights ... nonprofits, LAWRENCE, Kan., June 3 The ... international organization,representing highly trained professional medical illustrators and,animators, ... Works Act,of 2008" (H.R. 5889/S. 2913), pending in ...
... Parliament Heart Group meet today, 3 June, in Brussels, ... and how labelling of food can help people choose ... The European Commission has already made the declaration of ... on food packaging mandatory. Nevertheless, there is no European ...
... CHENGDU, China, June 2 Dogs which survived,the ... Sichuan China have a,new lease on life after ... ) and local officials announced an agreement to ... public health concerns through an IFAW,sponsored anti-rabies vaccination ...
... 2 Medifast, Inc.,(NYSE: MED ) announced today ... Officer, will make a presentation at the,Canaccord Adams Diabetes ... a.m. PT at the Hotel Nikko San Francisco., ... the event at, http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2301640 . The web,cast will be ...
Cached Medicine News:Health News:Climate change could impact vital functions of microbes 2Health News:Climate change could impact vital functions of microbes 3Health News:Orlando: June 13-16; National Convention on Mental Illness; Jane Pauley to Receive Award 2Health News:Association of Medical Illustrators Denounces 'Orphan Works' Bills Before Congress 2Health News:Members of European Parliament discuss food labeling and heart health 2Health News:Chinese Officials Cancel Dog Cull in Earthquake Zone 2Health News:Medifast, Inc. to Present at the Canaccord Adams Diabetes & Obesity Conference 2
ZYMAR™ ophthalmic solution is an anti-infective prescription eye drop that your doctor may instruct you to use if you have an eye infection caused by bacteria. Bacterial conjunctivitis is the e...
... lets you sleep on your ... the morning awake with your ... to take on the day. ... and protection, this preservative-free lubricant ...
Due to its thick formula, REFRESH CELLUVISC Lubricant Eye Drops is ideal for persistent dry eye conditions. REFRESH CELLUVISC provides lasting relief and protection for dry, scratchy eyes....
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
Medicine Products: